金吾财讯 | 康宁杰瑞制药(09966)公布,预期集团将于截至2024年12月31日止年度录得利润不少于人民币1.5亿元,而截至2023年12月31日止年度则录得亏损约人民币2.11亿元。此乃公司首次实现年度盈利。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.